EUVIMEDEUVIMED entdecken
Crossref

Zwitterionic Polymer Lipid Nanoparticles Enabling Selective Organ Targeting Delivery of Small Interfering RNA for the Treatment of Hepatic and Pulmonary Inflammation

Jiaxin Li, Nan Wang, Wen Zhang, Chen Peng, Xinyue Zhang, Muzi Li, Guanghui Ouyang, Yan Li iD

Small · 2025

DOI: 10.1002/smll.202407040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Jiaxin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technolog…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Nanoparticles, Polymers, Liver. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Beijing Nova Program, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are clinically advanced small interfering RNA (siRNA) carriers, which can prevent the breakdown of siRNA during delivery and deliver siRNA into the cytoplasm to down‐regulate the target gene. However, clinical LNPs are limited to the liver, and enhancing extrahepatic targeting is vital to expand the application of LNPs in vivo. Here, zwitterionic polymer LNPs (ZP‐LNPs) are assembled with the zwitterionic polymer polycarboxybetaine (PCB) modified 1,2‐dimyristoylglycerol (DMG) lipid DMG‐PCB n can selectively deliver siRNA to liver and lung, respectively. Three libraries with 90 ZP‐LNPs are established by adjusting the degree of polymerization of DMG‐PCB n , the molar ratio of lipids, and the mass ratio between lipids and siRNA. Physicochemical and in vivo biodistribution results show that B4‐3@siRNA and B5‐1@siRNA with high siRNA encapsulation efficiency (>85%) achieve targeted siRNA delivery to the liver and lung, respectively. The mechanism findings indicate that pKa and protein corona are essential to determine the in vivo fate of ZP‐LNPs and tendency for specific organs. Importantly, these two ZP‐LNPs with siTNF‐α can effectively reduce the levels of tumor necrosis factor α (TNF‐α) in mice with hepatic inflammation and pulmonary inflammation, respectively, indicating their promising application for the treatment of diseases associated with liver and lung.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingNanoparticlesPolymersLiverLipidsPneumoniaDrug Delivery SystemsAnimalsMiceHumansTissue DistributionLung

Stichwörter der Autor:innen

extrahepatic targetinginflammationlipid nanoparticlessmall interfering RNAzwitterionic polymer

Substanzen

RNA, Small InterferingPolymersLipids

Autor:innen und Institutionen

  • Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, China.
  • CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Zhongguancun, North First Street 2, Beijing, 100190, China.

ORCID-Profile: Yan Li

Förderung

  • Beijing Nova Program
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Wang, N., Zhang, W., Peng, C., Zhang, X., Li, M., Ouyang, G., & Li, Y. (2025). Zwitterionic Polymer Lipid Nanoparticles Enabling Selective Organ Targeting Delivery of Small Interfering RNA for the Treatment of Hepatic and Pulmonary Inflammation. Small. https://doi.org/10.1002/smll.202407040

Vancouver

Li J, Wang N, Zhang W, Peng C, Zhang X, Li M, et al. Zwitterionic Polymer Lipid Nanoparticles Enabling Selective Organ Targeting Delivery of Small Interfering RNA for the Treatment of Hepatic and Pulmonary Inflammation. Small. 2025. doi:10.1002/smll.202407040

BibTeX
@article{Li2025,
  author = {Li, Jiaxin and Wang, Nan and Zhang, Wen and Peng, Chen and Zhang, Xinyue and Li, Muzi and Ouyang, Guanghui and Li, Yan},
  title = {Zwitterionic Polymer Lipid Nanoparticles Enabling Selective Organ Targeting Delivery of Small Interfering RNA for the Treatment of Hepatic and Pulmonary Inflammation},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202407040}
}
Kostenlos starten →